Allarity Therapeutics, Inc. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Allarity Therapeutics, Inc. treasury stock, value, acquired, cost method for the quarter ending 2026-06-30 was $36.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. treasury stock, value, acquired, cost method for the quarter ending 2026-03-31 was $262.00K.
- Allarity Therapeutics, Inc. treasury stock, value, acquired, cost method for the quarter ending 2025-12-31 was $484.45K.
- Allarity Therapeutics, Inc. treasury stock, value, acquired, cost method for the quarter ending 2025-09-30 was $141.00K.
- Allarity Therapeutics, Inc. treasury stock, value, acquired, cost method for fiscal 2025 was $3.19M.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-30 | $36.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $887.49K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $262.00K 10-Q · filed 2026-08-14 | $3.45M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $484.45K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.19M 10-K · filed 2026-03-30 |
| 2025-09-30 | $141.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.56M 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |